Download PDF
Dtsch Med Wochenschr 2006; 131(46 spezial): H20-H23
DOI: 10.1055/s-2006-955057
Fortbildungsbeiträge | Continuing Medical Education
Hypertensiologie, Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Bewährte und neue Parameter hypertensiver Endorganschäden

Established and new parameters of hypertensive target organ damageB. M. W. Schmidt1 , R. E. Schmieder 1
  • 1Medizinische Klinik 4/Nephrologie und Hypertensiologie, Clinical Research Center, Universität Erlangen-Nürnberg
Further Information

Publication History

Publication Date:
09 November 2006 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Hypertonie - Endorganschäden

Key words

hypertension - target organ damage

Literatur

  • 1 Arnlov J, Evans J C, Meigs J B, Wang T J, Fox C S, Levy D. et al . Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals.  Circulation. 2005;  112 969-975
    CrossrefPubMedGoogle Scholar
  • 2 Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen J S. Urinary albumin excretion. An independent predictor of ischemic heart disease.  Arterioscler Thromb Vasc Biol. 1999;  19 1992-1997
    CrossrefPubMedGoogle Scholar
  • 3 Bottini P B, Carr A A, Prisant L M, Flickinger F W, Allison J D, Gottdiener J S. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient.  Am J Hypertens. 1995;  8 221-228
    CrossrefPubMedGoogle Scholar
  • 4 Chirinos J A, Zambrano J P, Chakko S. et al . Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.  Hypertension. 2005;  45 980-985
    CrossrefPubMedGoogle Scholar
  • 5 Dart A M, Gatzka C D, Kingwell B A. et al . Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives.  Hypertension. 2006;  47 785-790
    CrossrefPubMedGoogle Scholar
  • 6 Delles C, Michelson G, Harazny J, Oehmer S, Hilgers K F, Schmieder R E. Impaired endothelial function of the retinal vasculature in hypertensive patients.  Stroke. 2004;  35 1289-1293
    CrossrefPubMedGoogle Scholar
  • 7 Gonzalez A, Lopez B, Martin-Raymondi D. et al . Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients.  J Hypertens. 2005;  23 2297-2304
    PubMedGoogle Scholar
  • 8 Hillege H L, Fidler V, Diercks G F. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.  Circulation. 2002;  106 1777-1782
    CrossrefPubMedGoogle Scholar
  • 9 Ikram M K, de Jong F J, Bos M J. et al . Retinal vessel diameters and risk of stroke: the Rotterdam Study.  Neurology. 2006;  66 1339-1343
    CrossrefPubMedGoogle Scholar
  • 10 Klocke R, Cockcroft J R, Taylor G J, Hall I R, Blake D R. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis.  Ann Rheum Dis. 2003;  62 414-418
    CrossrefPubMedGoogle Scholar
  • 11 Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease.  Neurology. 2006;  67 224-228
    CrossrefPubMedGoogle Scholar
  • 12 Levey A S, Eckardt K U, Tsukamoto Y. et al . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).  Kidney Int. 2005;  67 2089-1100
    CrossrefPubMedGoogle Scholar
  • 13 London G M, Blacher J, Pannier B, Guerin A P, Marchais S J, Safar M E. Arterial wave reflections and survival in end-stage renal failure.  Hypertension. 2001;  38 434-438
    PubMedGoogle Scholar
  • 14 Lopez B, Gonzalez A, Querejeta R, Diez J. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease.  J Hypertens. 2005;  23 1445-1451
    PubMedGoogle Scholar
  • 15 Lhotta K, Kronenberg F, Mayer G. Errechnete Nierenfunktion: Nutzen und Problematik der MDRD-Formel.  Dtsch Med Wochenschr. 2005;  130 2021-2024
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Nürnberger J, Keflioglu-Scheiber A, Opazo Saez A M, Wenzel R R, Philipp T, Schafers R F. Augmentation index is associated with cardiovascular risk.  J Hypertens. 2002;  20 2407-2414
    Google Scholar
  • 17 Parikh N I, Hwang S J, Larson M G, Meigs J B, Levy D, Fox C S. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.  Arch Intern Med. 2006;  166 1884-1891
    CrossrefPubMedGoogle Scholar
  • 18 Ruilope L M, Salvetti A, Jamerson K. et al . Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.  J Am Soc Nephrol. 2001;  12 218-225
    PubMedGoogle Scholar
  • 19 Weber T, Auer J, O’Rourke M F. et al . Arterial stiffness, wave reflections, and the risk of coronary artery disease.  Circulation. 2004;  109 18418-18419
    PubMedGoogle Scholar
  • 20 Wong T Y, Klein R, Sharrett A R. et al . Cerebral white matter lesions, retinopathy, and incident clinical stroke.  JAMA. 2002;  288 67-74
    CrossrefPubMedGoogle Scholar
  • 21 Wong T Y, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality.  Br Med Bull. 2005;  73 - 74 57-70
    PubMedGoogle Scholar
  • 22 Yuyun M F, Khaw K T, Luben R. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population..  Am J Epidemiol. 2004;  159 284-293
    CrossrefPubMedGoogle Scholar

Prof. Dr. Roland E. Schmieder

Sprecher der KFO 106, Universität Erlangen-Nürnberg, Medizinische Klinik 4

Krankenhausstraße 12

91054 Erlangen

Phone: 09131/3982702

Fax: 09131/3983183

Email: roland.schmieder@rzmail.uni-erlangen.de

      >